[
  {
    "ts": null,
    "headline": "Jim Cramer on Intuitive Surgical: “One day, These Upside Surprises Will Come to an End”",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? I think that the lone surprise blowout next week will come from Intuitive Surgical, which had a monster quarter last time. But I bet that […]",
    "url": "https://finnhub.io/api/news?id=ad4931e4ff8ad15e9dec3874efe8222758ac99f0d4da2c9ee39b32e199eb66b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768924968,
      "headline": "Jim Cramer on Intuitive Surgical: “One day, These Upside Surprises Will Come to an End”",
      "id": 138188462,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? I think that the lone surprise blowout next week will come from Intuitive Surgical, which had a monster quarter last time. But I bet that […]",
      "url": "https://finnhub.io/api/news?id=ad4931e4ff8ad15e9dec3874efe8222758ac99f0d4da2c9ee39b32e199eb66b0"
    }
  },
  {
    "ts": null,
    "headline": "Robotic surgery fuels Johnson & Johnson dividend growth outlook",
    "summary": "Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification. That's a big deal because it marks J&J's formal entry into the fast-growing robotic ...",
    "url": "https://finnhub.io/api/news?id=f147a8bd005145aa567d4571b68338450bac1aeb1034acda45c860cacf5621f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768923420,
      "headline": "Robotic surgery fuels Johnson & Johnson dividend growth outlook",
      "id": 138187435,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ISRG",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification. That's a big deal because it marks J&J's formal entry into the fast-growing robotic ...",
      "url": "https://finnhub.io/api/news?id=f147a8bd005145aa567d4571b68338450bac1aeb1034acda45c860cacf5621f0"
    }
  },
  {
    "ts": null,
    "headline": "CURE: Benefits And Caveats Of The Leveraged Healthcare ETF",
    "summary": "Direxion CURE ETF offers 3x daily healthcare exposureâlearn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.",
    "url": "https://finnhub.io/api/news?id=ca3612c5b4891b901620bb4fdb6c38f001242d9ac0824dccbf1890b2577a24b9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768912790,
      "headline": "CURE: Benefits And Caveats Of The Leveraged Healthcare ETF",
      "id": 138188296,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1351287260/image_1351287260.jpg?io=getty-c-w1536",
      "related": "ISRG",
      "source": "SeekingAlpha",
      "summary": "Direxion CURE ETF offers 3x daily healthcare exposureâlearn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.",
      "url": "https://finnhub.io/api/news?id=ca3612c5b4891b901620bb4fdb6c38f001242d9ac0824dccbf1890b2577a24b9"
    }
  }
]